Senior Scientist, In vivo pharmacology
Marengo Therapeutics Inc
Summary
Marengo Therapeutics is developing first-in-class bi-specific T cell activators that stimulate and expand anti-tumor T cells to generate deep, durable anti-tumor immunity. Our lead program is in Phase 2 clinical trials, currently being evaluated across multiple solid tumor indications, backed by an advanced antibody discovery platform and a growing pipeline of multi-specific immune-modulating therapeutics.
Job description
About this role
Marengo Therapeutics is developing first-in-class bi-specific T cell activators that stimulate and expand anti-tumor T cells to generate deep, durable anti-tumor immunity. Our lead program is in Phase 2 clinical trials, currently being evaluated across multiple solid tumor indications, backed by an advanced antibody discovery platform and a growing pipeline of multi-specific immune-modulating therapeutics.
Building on that clinical foundation, our TriSTAR™ platform is enabling the development of a new generation of precision T cell engagers (TCEs). TriSTAR molecules are multi-specific antibody fusions that pair our proprietary antibodies against germline-encoded Vß regions of the TCR with a T cell co-stimulatory moiety and a tumor-associated antigen binder — selectively activating and expanding memory Vß T cell subsets while redirecting them to the tumor in a single molecule.
We are seeking an experienced and highly motivated In vivo Pharmacologist to join our Immunology research team. As a member of Marengo's Immunology research team, you will contribute to the characterization of novel T cell-engagers by driving in vivo pharmacology studies towards the identification of clinical candidates.
Key Responsibilities
- Develop clear, fully resourced research plans for project progression and deliver against agreed timelines.
- Spend at least 60-70% of time on hands-on laboratory and in vivo work, personally conducting studies in the vivarium and lab rather than solely overseeing them.
- Design, execute hands-on, and interpret a wide range of in vivo pharmacology studies (PK, PD, efficacy, antigen-driven biodistribution, and biomarker discovery) to assess drug exposure, target engagement, anti-tumor activity, and mechanism of action, and to identify biomarkers.
- Personally perform in vivo procedures, including tumor cell implantation, test article dosing by multiple routes (e.g., IV, IP, SC, PO), tumor measurement, body weight and clinical observation monitoring, necropsy and blood and tissues collection.
- Be available for occasional early-morning, evening, or weekend work to support study time points such as PK sampling, dosing schedules, and animal monitoring.
- Process and analyze study samples hands-on, including tissue dissociation, flow cytometry, ELISA and multiplex cytokine assays, and prepare samples for IHC and multiplexed IF.
- Derive actionable biological conclusions from study data and propose new experiments based on the findings.
- Maintain accurate, up-to-date records of experimental data in the electronic lab notebook (ELN).
- Author documents in support of regulatory submissions and contribute to the scientific literature through publications and presentations.
- Generate ideas and conduct research to identify new opportunities for the continued evolution of Marengo's in vivo pharmacology platform.
- Drive and work effectively within cross-functional teams in a matrix environment, running critical studies that advance lead and drug candidates to key inflection points.
- Engage with broader project teams to advance portfolio projects.
- Manage the vivarium relationship, and keep animal protocols current as needed.
Qualifications
Required
- PhD with 5+ years, or MS with 8+ years, of directly relevant pharmaceutical or biotech industry experience in cancer immunology, T cell biology, immuno-oncology, or a related discipline, with a focus on in vivo pharmacology.
- Demonstrated recent hands-on experience performing in vivo studies, including rodent handling, dosing by multiple routes, tumor implantation and measurement, blood and tissue collection, and necropsy.
- Expertise in oncology and immuno-oncology in vivo models, with emphasis on humanized cell-line derived and/or patient-derived xenograft (PDX) models.
- Deep understanding of biologics drug discovery and early-stage development, particularly building the pharmacology package required for candidate drug nomination.
Preferred
- Experience developing humanized mouse models for oncology platforms.
- Experience designing and executing PK, PK/PD, biodistribution, efficacy, and mechanistic in vivo studies.
- Hands-on proficiency in molecular and cell biology techniques such as ELISA, multiplex cytokine assays, flow cytometry, or IHC.
- Familiarity with Studylog.
- Ability to turn complex scientific problems into clear strategy and tactics.
- Ability to present projects to internal and external teams to support decisions at key inflection points.
- Excellent verbal, written, and interpersonal communication skills.
- Strong attention to detail, with excellent organizational and record-keeping skills.
Requirements
- PhD with 5+ years, or MS with 8+ years, of directly relevant pharmaceutical or biotech industry experience in cancer immunology, T cell biology, immuno-oncology, or a related discipline, with a focus on in vivo pharmacology
- Demonstrated recent hands-on experience performing in vivo studies, including rodent handling, dosing by multiple routes, tumor implantation and measurement, blood and tissue collection, and necropsy
- Expertise in oncology and immuno-oncology in vivo models, with emphasis on humanized cell-line derived and/or patient-derived xenograft (PDX) models
- Deep understanding of biologics drug discovery and early-stage development, particularly building the pharmacology package required for candidate drug nomination
- Experience developing humanized mouse models for oncology platforms
- Experience designing and executing PK, PK/PD, biodistribution, efficacy, and mechanistic in vivo studies
- Hands-on proficiency in molecular and cell biology techniques such as ELISA, multiplex cytokine assays, flow cytometry, or IHC
- Familiarity with Studylog
- Ability to turn complex scientific problems into clear strategy and tactics
- Ability to present projects to internal and external teams to support decisions at key inflection points
- Excellent verbal, written, and interpersonal communication skills
- Strong attention to detail, with excellent organizational and record-keeping skills
Company overview
Marengo Therapeutics is a clinical-stage biotechnology company pioneering novel immunotherapies for cancer treatment. Based in Cambridge, Massachusetts, the company focuses on developing first-in-class therapeutics that activate the body's immune system to mount rapid, effective, and durable responses against cancer. Their unique therapeutic platform selectively boosts T cells, enhancing potent anti-tumor activity while promoting long-term immunity. Marengo's lead asset, Invikafusp Alfa, is currently in Phase 2 clinical trials for various solid tumors, demonstrating promising results in tissue-agnostic TMB-H cancers and metastatic breast cancer. The company's innovative approach targets the right activation of specific immune cells to achieve lifelong protection against cancer, representing a new frontier in immuno-oncology. With a team of approximately 42 employees, Marengo has secured significant funding, including an $80 million Series B round led by Apple Tree Partners, and has been recognized as a Great Place to Work for its collaborative and innovative culture.